These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
357 related items for PubMed ID: 17638896
1. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer. Araki S, Omori Y, Lyn D, Singh RK, Meinbach DM, Sandman Y, Lokeshwar VB, Lokeshwar BL. Cancer Res; 2007 Jul 15; 67(14):6854-62. PubMed ID: 17638896 [Abstract] [Full Text] [Related]
2. Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells. Lee SO, Pinder E, Chun JY, Lou W, Sun M, Gao AC. Prostate; 2008 Jan 01; 68(1):85-91. PubMed ID: 18008330 [Abstract] [Full Text] [Related]
4. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Zhang F, Lee J, Lu S, Pettaway CA, Dong Z. Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637 [Abstract] [Full Text] [Related]
5. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. Levine L, Lucci JA, Pazdrak B, Cheng JZ, Guo YS, Townsend CM, Hellmich MR. Cancer Res; 2003 Jul 01; 63(13):3495-502. PubMed ID: 12839933 [Abstract] [Full Text] [Related]
6. CL1-GFP: an androgen independent metastatic tumor model for prostate cancer. Patel BJ, Pantuck AJ, Zisman A, Tsui KH, Paik SH, Caliliw R, Sheriff S, Wu L, deKernion JB, Tso CL, Belldegrun AS. J Urol; 2000 Oct 01; 164(4):1420-5. PubMed ID: 10992426 [Abstract] [Full Text] [Related]
7. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice. Jin RJ, Wang Y, Masumori N, Ishii K, Tsukamoto T, Shappell SB, Hayward SW, Kasper S, Matusik RJ. Cancer Res; 2004 Aug 01; 64(15):5489-95. PubMed ID: 15289359 [Abstract] [Full Text] [Related]
8. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression. Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B. Prostate; 2008 Mar 01; 68(4):453-61. PubMed ID: 18196538 [Abstract] [Full Text] [Related]
10. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R). Ling MT, Wang X, Lee DT, Tam PC, Tsao SW, Wong YC. Carcinogenesis; 2004 Apr 01; 25(4):517-25. PubMed ID: 14688027 [Abstract] [Full Text] [Related]
11. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Nickerson T, Chang F, Lorimer D, Smeekens SP, Sawyers CL, Pollak M. Cancer Res; 2001 Aug 15; 61(16):6276-80. PubMed ID: 11507082 [Abstract] [Full Text] [Related]
12. Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation. Seaton A, Scullin P, Maxwell PJ, Wilson C, Pettigrew J, Gallagher R, O'Sullivan JM, Johnston PG, Waugh DJ. Carcinogenesis; 2008 Jun 15; 29(6):1148-56. PubMed ID: 18487223 [Abstract] [Full Text] [Related]
13. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice. Lu S, Lee J, Revelo M, Wang X, Lu S, Dong Z. Clin Cancer Res; 2007 Oct 01; 13(19):5692-702. PubMed ID: 17908958 [Abstract] [Full Text] [Related]
14. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Gregory CW, Johnson RT, Mohler JL, French FS, Wilson EM. Cancer Res; 2001 Apr 01; 61(7):2892-8. PubMed ID: 11306464 [Abstract] [Full Text] [Related]
15. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations. Shi Y, Chatterjee SJ, Brands FH, Shi SR, Pootrakul L, Taylor CR, Datar R, Cote RJ. BJU Int; 2006 Jan 01; 97(1):170-8. PubMed ID: 16336351 [Abstract] [Full Text] [Related]
16. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK. Lee LF, Louie MC, Desai SJ, Yang J, Chen HW, Evans CP, Kung HJ. Oncogene; 2004 Mar 18; 23(12):2197-205. PubMed ID: 14767470 [Abstract] [Full Text] [Related]
17. Interleukin-4 in patients with prostate cancer. Takeshi U, Sadar MD, Suzuki H, Akakura K, Sakamoto S, Shimbo M, Suyama T, Imamoto T, Komiya A, Yukio N, Ichikawa T. Anticancer Res; 2005 Mar 18; 25(6C):4595-8. PubMed ID: 16334148 [Abstract] [Full Text] [Related]
18. Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice. Wallner L, Dai J, Escara-Wilke J, Zhang J, Yao Z, Lu Y, Trikha M, Nemeth JA, Zaki MH, Keller ET. Cancer Res; 2006 Mar 15; 66(6):3087-95. PubMed ID: 16540658 [Abstract] [Full Text] [Related]
19. Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression. Cheng H, Snoek R, Ghaidi F, Cox ME, Rennie PS. Cancer Res; 2006 Nov 01; 66(21):10613-20. PubMed ID: 17079486 [Abstract] [Full Text] [Related]
20. Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor. Malinowska K, Neuwirt H, Cavarretta IT, Bektic J, Steiner H, Dietrich H, Moser PL, Fuchs D, Hobisch A, Culig Z. Endocr Relat Cancer; 2009 Mar 01; 16(1):155-69. PubMed ID: 19011039 [Abstract] [Full Text] [Related] Page: [Next] [New Search]